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Abstract
The performance of a pan-fungal PCR-based technique was evaluated to assess the aetiology of invasive fungal diseases (IFDs). A total of 89
formalin-fixed paraffin-embedded biopsy samples from 84 patients with proven IFD were studied. Culture of tissue was performed in 68
(81%) patients. The sensitivities of the PCR-based technique and microbiological culture of tissues were 89% and 56%, respectively
(p <0.01). According to PCR results, Aspergillus species accounted for 67%, Candida species for 13%, zygomycetes for 11%, and rare and
emerging fungi for 9%. Aspergillus species were significantly associated with lung samples (79.6%, p <0.01), Mucorales were associated with
skin/subcutaneous samples, and Candida species were associated with gastrointestinal samples. Regarding biopsy samples with Aspergillus
species, Aspergillus fumigatus DNA was detected in 43 of 50 (86%), and Aspergillus flavus in six of 50 (12%). PCR was positive in 24 of 30 (80%)
cases with negative culture. In nine of the 84 patients, the PCR technique failed to amplify the DNA. Six also had negative cultures, and in the
remaining three cases culture was positive (Rhizopus microsporus, Rhizopus arrhizus, and Sakseneae vasiformis), suggesting that the PCR
technique was not as effective in amplifying the DNA of some species of Zygomycetes. In five cases, there was no correlation between
culture results and those obtained with DNA amplification, indicating the possibility of a mixed infection or the presence of colonizer/
contaminant microorganisms. In summary, PCR-based techniques for DNA amplification should be implemented in histopathology and
microbiology departments, as they appear to be complementary to conventional methods for IFD detection.
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Introduction
The diagnosis of invasive fungal diseases (IFDs) continues to be
problematic [1,2]. Classical methods such as culture, where
several days are required to observe growth, are not effective
for early diagnosis. In addition, the specificity of culture is
moderate, as fungi are habitual contaminants in the laboratory,
and form part of the saprophytic flora. A retrospective study
by Chamilos et al. [3] described 60% of IFDs in which hyphae
were observed in the tissues and cultures were negative.
Microscopic examination and histopathological studies have
significant drawbacks; it is possible to observe fungal structures
under the microscope only when the infection is at a very
advanced stage, and sensitivity depends on the level of
magnification of the microscope, as well as on the number of
fields examined. Histopathological studies can distinguish IFDs
caused by hyaline moulds from those caused by black fungi, and
sometimes zygomycetes can also be identified, although it is
not always easy to distinguish these when there is a scarcity of
hyphae [4]. The most important limitation of tissue observa-
tion is the impossibility of differentiating the species, which is
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essential for determining therapy, given the differences in
sensitivity to antifungal agents among emerging fungi [4,5].
PCR-based molecular techniques enable the fast and
sensitive identification at a species level by detecting small
amounts of DNA in serum and blood [4,6,7]. Although these
techniques have yet to be standardized, many recent studies
have shown the usefulness of them in the amplification of
fungal DNA in tissues, such as the detection of the ITS region
of rDNA [8,9], of mitochondrial regions [5], or of the 28S
region [10]. Real-time PCR techniques have also been
described for the detection of less frequent species, such as
Scedosporium [11], Zygomycota [12,13] and Fusarium species in
biopsy samples [14]. The sensitivity and specificity results of
these studies are variable, but in all cases there is an improved
sensitivity over classical methods, and results are obtained in a
quick and specific manner [15,16].
This article reports a retrospective study using an auto-
mated real-time PCR-based technique on formalin-fixed par-
affin-embedded biopsy samples from two Spanish hospitals.
The performance of the real-time PCR-based procedures was
analysed, and comparisons with those of culture and histo-
pathological studies were performed. The ability of the
molecular techniques to detect and to identify the fungal
DNA at the species level was evaluated. The exercise was
designed to amplify fungal DNA of common species such as
Candida and Aspergillus species, and also of emerging and rare
fungal pathogens.
Materials and Methods
A total of 89 formalin-fixed paraffin-embedded biopsy samples
from 84 different patients were analysed, originating from the
departments of pathology and microbiology of two hospitals
from Madrid, Spain: Hospital Universitario 12 de Octubre (H1)
(population: 550 000 inhabitants), a 1300-bed tertiary general
hospital that performs 300 solid organ transplants and 50
haematopoietic cell transplants per year; and Hospital Univer-
sitario La Paz (H2) (population: 855 000 inhabitants), a 1300-
bed tertiary general hospital that performs an average of 55
haematopoietic cell transplants and 150 solid organ transplants
per year. Members of the hospital departments reviewed their
databases, looking for the results of all samples of tissue
biopsies analysed in last 10 years that had been classified as
IFD, invasive fungal infection, invasive mycosis, fungal infection
or mycosis after histopathological examination by Gomori–
Grocott methenamine silver stain and/or haematoxylin and
eosin stain.
After database review, a total of 89 tissue biopsy samples
were selected and sent to the Spanish Mycology Reference
Laboratory of the National Centre for Microbiology for PCR
analysis. The H1 centre sent 39 paraffin biopsy samples from
35 different patients. The H2 centre sent 50 paraffin biopsy
samples from 49 different patients. Clinical data of patients and
the results of microbiological cultures, microscopic examina-
tions and histopathological studies were also reviewed.
For PCR analysis, the paraffin blocks were cut into 10-lm
sections. Three to ten cuts were used to extract the DNA,
with the number of cuts being varied in order to obtain
approximately 25 mg of tissue. Biopsy samples in paraffin were
deparaffined by lavage with 1.5 mL of xylene (100%) followed
by two lavages with 1.2 mL of ethanol (96–100%). After
incubation of the tissue at 37°C to evaporate the remains of
the ethanol, DNA was extracted with the QiAmp Tissue DNA
Mini Kit (Qiagen, Izasa, Madrid, Spain), according to the
manufacturer’s instructions. Fifty microlitres of buffer was
used for elution. Two microlitres of DNA extracted from each
sample was used for each PCR reaction.
PCR reactions performed in an LC480 unit (Roche, Madrid,
Spain). The ITS1 region of the rDNA was amplified with the
universal primers ITS1 (5′-TCCGTAGGTGAACCTGCGG-3′)
and ITS2 (5′-GCTGCGTTCTTCATCGATGC-3′) [17]. The
2 9 Sensimix DNA (Quantace, Ecogen, Madrid, Spain) kit was
used, according to the manufacturer’s instructions. The PCR
reaction (20 lL) contained 0.8 lM each primer, 4.5 mM
MgCl2, and SYBR Green I binding dye (Quantace). The
conditions for the PCR reaction included a first phase of
pre-incubation (enzyme activation) and DNA denaturation at
95°C for 10 min. The next steps included a 45-cycle
amplification programme, as follows: denaturation for 10 s
at 95°C, 5 s of annealing at 54°C, and 30 s of extension at
72°C. A melting program from 65°C to 97°C was also
performed. Melting curves were analysed to discriminate
unspecific amplifications from true amplicons, as a PCR
amplification control. Four controls were included (DNA of
the Aspergillus fumigatus CNM-CM-237 strain) at various
concentrations (2 pg to 2 fg per 20 lL) with each sample
set, as well as negative controls. Agarose gel electrophoresis
was performed at 1.5% (Sigma-Aldrich Quimica, Madrid, Spain)
with Tris–acetate–EDTA, following the usual protocols [18],
in order to verify amplification and the quality of the amplified
products. PCR products were sequenced (ABI 3730 XL;
Applied Biosystems, Madrid, Spain) with ITS1 and ITS2
primers. The sequences obtained were compared with the
GenBank database (http://www.ncbi.nih.gov/Genbank/) and
with the database belonging to the Department of Mycology
of the Spanish National Centre for Microbiology, which holds
5000 sequences from strains belonging to 270 different fungal
species. This database was designed by the Spanish National
Centre for Microbiology, and has restricted access. The
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complete procedure was repeated two times on different
days.
Descriptive and comparative analyses were performed.
Differences in proportions of positive PCR, culture and
histopathological examination results were determined with
Fisher’s exact test or by chi-square analysis. The analysis of
concordance between histopathological, microbiological and
PCR results was performed with the gamma ordinal proba-
bilistic measure. It summarizes, on a 1 to +1 scale, the extent
to which higher categories (based on the data codes used) of
one variable are associated with higher categories of the
second variable. The data codes used for results were as
follows: negative = 0, hyaline hyphae with septae/aspergillo-
sis = 1, non-septated hyphae/mucormycosis = 2, yeasts/cand-
idosis = 3, and fungal structures = 4. A p-value of <0.01 was
considered to be statistically significant. Statistical analysis was
performed with IBM SPSS 19.0 (SPSS Iberica, Madrid, Spain).
Results
Clinical characteristics
A total of 84 patients diagnosed as having IFD were reviewed.
Table 1 shows underlying diseases and sites of localization of
IFD. The most common underlying conditions were onco-
haematological diseases (29/84, 34.5%), followed by chronic
respiratory diseases (21/84, 25%) and solid organ transplanta-
tion (12/84, 14.3%). The most frequent localizations of IFD
were lung diseases in 54 (64.3%) patients who presented with
respiratory symptom infection such as lung infiltrates, nodules,
and cavitary lesions. The second most common infection was
skin/subcutaneous infection (nine cases, 10.7%). Other patients
had sinonasal infections, oropharyngeal symptoms, gastroin-
testinal diseases, and urinary infections (Table 1).
Histopathological data
A total of 89 tissue biopsy samples from 84 different patients
were analysed. Tissue sampling was performed according to
the main symptoms of patients: 64.3% of biopsy samples were
lung samples, 10.7% were skin/subcutaneous samples, 7.1%
were gastrointestinal samples, and 18% were from other deep
sites. Hyphae or fungal structures were observed in all of them
by analysis of the tissues under the microscope.
Tissue lesions were classified as being caused by hyaline
hyphae with septae, by non-septated hyphae, by yeast, and by
fungal structures. Black fungi were not found. Anatomical
pathologists reported 58.3% (49/84 cases) to be mycoses
caused by hyaline species with septae, and suggested Aspergillus
as the possible agent responsible for infection in 25 cases (25/
49, 51%). Filamentous species without septae were reported in
18 of 84 (21.4%) cases, being suggested mycoses caused by
Mucorales species in 14 of 18 (77.8%) patients. Yeasts were
found in six cases (6/84, 7%), with histopathological reports
stating that Candida-like forms had been seen, accompanied by
evidence of associated tissue damage in 100% (6/6) of cases.
Fungal structures were observed in only 11 of 84 patients
(13%), and microscopic examinations were unable to provide
any further data (Table 2).
Microbiological cultures
Cultures were performed for 68 of 84 (81%) patients. The
samples collected were sent for histopathological and cyto-
logical evaluation, and not for microbiological study, in the
remaining 19% of cases. Cultures were negative in 30 of 68
(44%) cases, and the sensitivity of cultures can therefore be
considered to be 56% relative to histopathological results.
With regard to fungal species, Aspergillus species were the
most common among culture-positive cases (21/68, 30.9%),
and Mucorales and Candida species were the second (9/68,
13.2%) and third (7/68, 10.3%) most common species. Some
significant epidemiological differences (p <0.01) were
observed between hospitals; for example, Mucorales species
were isolated much more frequently among patients of centre
H1 (25.8%) than among patients of centre H2 (3%). A bias in
this observation should be noted, as almost one-fifth of cases
were not referred to microbiological departments for culture.
With regard to type of tissue lesion according to the
histopathological report, microbiological cultures were positive
in 21 of 38 (55%) of cases caused by hyaline hyphae with septae
TABLE 1. Underlying diseases and fungal infections of 84
patients included in the study
Underlying disease Fungal infection
Number
of cases
Onco-haematological Lung 21
Sinonasal 2
Skin/subcutaneous 1
Oropharyngeal 3
Vascular 1
Cerebral 1
Total 29 (34.5%)
Respiratory Lung 21
Total 21 (25%)
Solid organ transplant Lung 5
Sinonasal 2
Skin/subcutaneous 2
Gastrointestinal 2
Urinary 1
Total 12 (14.3%)
Polytrauma Skin/subcutaneous 4
Oropharyngeal 1
Total 5 (5.9%)
Others Lung 7
Sinonasal 2
Skin/subcutaneous 2
Gastrointestinal 3
Urinary 1
Oropharyngeal 1
Vascular 1
Total 17 (20.2%)
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whose samples were cultured for microbiological evaluation.
Sensitivity rates were similar for cases reported as being caused
by non-septated hyphae (70%) and by yeasts (66%). Regarding
cases reported as fungal structures, microbiological cultures
were performed in six cases, and all were negative. No
differences were observed by type of tissue biopsy.
PCR results
The PCR-based technique detected fungal DNA in 75 of 84
patients (89.3%) (Table 2). Notably, DNA amplification was
positive in 80% (24/30) of patients diagnosed with IFD with
negative cultures. In six of nine patients with a negative PCR
result, microbiological cultures were also negative. PCR-
negative results were not significantly associated with institu-
tion, type of patient, tissue biopsy, or fungal species.
The species distribution in positive biopsy samples was as
follows: 50 of 75 (66.6%) cases harboured DNA of Aspergillus
species, 11 of 75 (14.6%) harboured DNA of Candida and
other yeasts (one Cryptococcus neoformans and one Udeniomy-
ces species), nine of 75 (12%) harboured DNA of Mucorales
species, and five harboured DNA of other mould species.
Regarding biopsy samples with Aspergillus species, A. fumigatus
DNA was detected in 43 of 50 (86%), Aspergillus flavus in six of
50 (12%), and Aspergillus niger in one of 50 (2%). Aspergillus
terreus DNA was not detected in any case. Regarding
Mucorales, five of nine cases harboured DNA of Rhizopus
oryzae and three harboured DNA of Lichtheimia species. Rare
fungi were Scedosporium apiospermum, Hyaloperonospora par-
asitica, Schizophillum commune, Aureobasidium pullulans, and
Phoma species.
With regard to type of tissue biopsy, Aspergillus species
were significantly associated with lung biopsy, as 43 of 54
(79.6%) lung biopsy samples harboured Aspergillus DNA
(p <0.01). Mucorales species were associated with skin/
subcutaneous samples (5/9, 55.5%), and Candida species with
gastrointestinal samples (3/6, 50%).
Some significant differences were observed between insti-
tutions. The most common species detected with the PCR-
based technique were Aspergillus species in both centres, but
their rate in the H1 centre was 34.5% and their rate in the H2
centre was 86.9% (p <0.01). Candida species were the second
most common organisms (31%) and Mucorales the third most
common (20.7%) in the H1 centre, according to PCR results.
Mucorales (6.5%) and Candida species (4.3%) were the second
and third most common species, respectively, in the H2
centre.
Correlation between PCR results, histopathological reports,
and microbiological culture
As stated above, the sensitivity of microbiological culture was
56% and the sensitivity of the PCR-based technique was 89.3%
when histopathological reports were used as a reference to
compare the performance of culture and DNA amplification in
detecting IFDs. Notably, DNA amplification was positive in
80% (24/30) of patients diagnosed with IFD with negative
cultures.
The gamma probabilistic measure between histopatholog-
ical microscopic examination, microbiological results and PCR-
based identification was statistically significant (p <0.01), taking
into account positive cultures and PCR results only. Gamma
Histopathological
report
Number
of cases Culture results
Number
of cases PCR results
Number
of cases
Hyaline hyphae with septae 49 Aspergillus spp. 18 Aspergillus spp. 17
Phoma spp. 1
Candida spp. 2 Aspergillus spp. 2
Scedosporium
apiospermum
1 Scedosporium
apiospermum
1
Negative 17 Aspergillus spp. 12
Zygomycota spp. 2
Negative 3
Not done 11 Aspergillus spp. 9
Candida spp. 2
Non-septated hyphae 18 Zygomycota
spp.
9 Zygomycota spp. 5
Candida spp. 1
Negative 3
Aspergillus spp. 3 Aspergillus spp. 2
Candida spp. 1
Candida spp. 1 Candida spp. 1
Negative 5 Zygomycota spp. 2
Aspergillus spp. 1
Negative 2
Yeasts 6 Candida spp. 4 Candida spp. 4
Negative 2 Candida spp. 2
Fungal structures 11 Negative 6 Aspergillus spp. 4
Hyaloperonospora
parasitica
1
Negative 1
Not done 5 Aspergillus spp. 3
Other speciesa 2
aSchizophillum commune and Aureobasidium pullulans.
TABLE 2. Histopathological analy-
sis and culture results of samples of
patients included in the study
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index values were 0.65 between histopathological and culture
results, 0.68 between microscopic examination and PCR
results, and 0.76 between culture and PCR data. These values
were significant, but some discrepancies were observed.
Hyaline hyphae with septae had been reported in 49 cases,
but PCR results were negative in three of 49 (6.1%), and PCR
detected Mucorales in another two of 49 (4%) cases.
Regarding microscopic examination reporting non-septated
hyphae, PCR was not able to detect fungal DNA in five of 18
(27.7%) patients, and PCR identified Aspergillus species in three
of 18 (16.6%) cases classified as probable mucormycosis by
histopathological examination.
Analysis can be performed for the six cases with negative
culture and PCR results. They were three cases with hyaline
septated hyphae, two cases with non-septated hyphae, and one
for which histopathological examination reported fungal
structures.
Discussion
The aim of this study was to ascertain the aetiology of IFDs by
using a PCR-based molecular technique as a complementary
procedure to microscopic examination and microbiological
culture. Such techniques have proven to be very useful for the
correct identification of fungal species, and have also assisted
in the taxonomic reclassification of many groups [1]. Correct
identification is essential for the correct choice of antifungal
treatment, particularly in cases caused by emerging and rare
species, which are often resistant to some antifungal agents. In
order to strengthen its representativeness, the study was
designed to analyse retrospectively tissue biopsies from two
different Spanish tertiary hospitals, including all cases diag-
nosed with IFD in the last 10 years in both hospitals.
Additionally, the study was intended to evaluate a PCR-based
method including a commercial extraction method without
preliminary fungal cell breakage steps, and an automated
quantitative PCR technique that is easy to perform in a clinical
laboratory.
One of the first findings was the low sensitivity of
cultures, which was estimated to be 56%. No significant
differences were observed by institution, tissue biopsy, or
fungal species. Several reasons for the poor performance of
cultures can be suggested, such as the scarcity of fungal cells
in the sample, inhibition by tissue components or antifungal
agents, and methodological limitations (lack of inoculation
onto a diverse range of culture media, and incubation at
both 30°C and 37°C).
The PCR technique evaluated in the exercise showed a
sensitivity of 89%, which is significantly higher than that of
culture (p <0.01). PCR was positive in 80% of cases with
negative culture, and thus showed a remarkably good
performance. In only nine cases did the PCR technique fail
to amplify the DNA, and, in six of these, microbiological
culture was also negative. There were three cases for which
cultures were positive and the PCR technique was negative.
Those three cases were caused by the Mucorales species
Rhizopus microsporus, Rhizopus arrhizus, and Sakseneae
vasiformis. This suggests that the ITS1 and ITS2 primers
may not be effective in amplifying the species of this group,
as has previously been described for certain zygomycetes
[8,19].
In five cases, there was no correlation between culture
results and those obtained by DNA amplification. Four of
those cases were patients suffering from a respiratory
infection, and the fifth one was diagnosed with gastric
mucormycosis. Cultures from two cases of respiratory
infection yielded Aspergillosis species, whereas DNA amplifica-
tion yielded Candida albicans and Phoma species. Another two
cases of respiratory disease had culture yielding Candida
species, but both PCR results were Aspergillus species.
R. microsporus was cultured from the patient with a gastric
infection, whereas DNA of C. albicans was amplified by the
PCR-based assay performed on the gastric biopsies. Taking
into account the clinical entity and the histopathological
examination (hyaline septated hyphae were observed in the
four cases of respiratory infection and non-septated hyphae in
the patient suffering from a gastric infection), the DNA
amplification could have been more accurate for two of four
cases of respiratory fungal disease. In other cases, the
possibility of a mixed infection or the presence of the
microorganism detected as the colonizer by PCR cannot be
ruled out.
These results show that microbiological culture and
molecular techniques can be complementary procedures for
IFD detection. It should be stressed that culture was not
performed in 19% of cases. Clinical microbiologists should
strive to inform the appropriate clinical units to request both
histopathology and microbiological/mycological investigations.
Histopathology was considered to be the reference tech-
nique in this study, because, in many cases, it is the only
method that makes it possible to detect infection [20].
However, microscopy cannot be considered to be an early
diagnostic technique or one by means of which it is possible to
classify the species causing the fungal infection. Histopatho-
logical examinations are able to determine whether the
infection is caused by yeasts or by mycelial fungi, and whether
one of the latter group is an agent of hyalohyphomycosis,
phaeohyphomycosis, or zygomycosis. Expertise is usually
needed for interpretation, and the reliability is decreased
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when an inexperienced observer examines the sample. The
concordance between the results of microscopy, culture and
PCR proves the reliability of histopathological examination.
However, some results show its limitations. The DNA
amplification technique found seven cases caused by Aspergillus
species that the histopathologist reported as invasion caused
by fungal structures. Six of those cases were negative by
culture, which could indicate that it is possible to view fungal
structures only when they are very abundant in the sample to
be analysed, which is usually the case when the infection is at
an advanced stage. Therefore, histopathological diagnosis
should be primarily descriptive of the fungus (hyphae and
septa), and should include the presence or absence of tissue
invasion and the host reaction to the infection.
Regarding epidemiology, the DNA amplification and con-
ventional techniques were complementary to each other, and
the PCR-based method helped us with classification at the
species level of most IFD cases. The genus Aspergillus
accounted for 67% of all samples analysed, but it must be
pointed out that the percentage of zygomycetes and rare and
emerging fungi accounted for 20%.
The PCR-based techniques should be implemented in
histopathology and microbiology departments, as they appear
to be complementary techniques to conventional methods
for IFD detection. The pan-fungal PCR-based procedure
evaluated in this exercise showed much higher sensitivity
than microbiological culture, and its performance could be
regarded as better than that of microscopic examination, as
the molecular method was useful for fungal species identi-
fication. Limitations should also be considered, such as the
facts that pan-fungal PCR could be less sensitive for the
detection of some fungal species, and the possibility of a
mixed infection or the presence of the microorganism
detected as the colonizer or contaminant cannot be ruled
out.
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